期刊文献+

精神分裂症患者代谢综合征的患病率及相关因素 被引量:15

Prevalence Rate of Metabolic Syndrome and Associated Factors in Patients with Schizophrenia
下载PDF
导出
摘要 目的探索精神分裂症患者伴发代谢综合征的患病率及相关因素。方法对使用单一非典型精神病药物6月以上的精神分裂症患者做调查,测定其代谢指标,采用世界糖尿病联盟(IDF,2005)全球统一标准定义代谢综合征(MS),了解精神分裂症患者伴发代谢综合征的发生率,用Logistic回归分析影响发生的相关因素。结果共入组完成386例,MS患病率为35.8%,MS患病率随年龄、病程的增加而增加(P<0.001),同时与服药有关。Logistis回归分析结果显示,年龄、病程进入方程(P<0.01)。结论非典型抗精神病药引起代谢综合征发生率高于普通人群,可能的危险因素有高龄、长病程。 Objective To explore the prevalence rate and associated factors of metabolic syndrome in patients with schizophrenia.Methods To investigate patients with schizophrenia who used single atypical antipsychotic drugs over 6 months,and test their metabolic index in accordance with the unified global standard definitions of metabolic syndrome in IDF in order to understand the prevalence rate of metabolic syndrome in patients with schizophrenia and analyze associated factors of metabolic syndrome by Logistic.Results The prevalence rate of MS in all 386 patients was 35.8%,prevalence rate increased with age and course of disease(P〈0.001),and also with relation to the medication.Age and course of disease entered equation(P〈0.01).Conclusion Incidence rate of metabolic syndrome in patients with schizophrenia taking atypical antipsychotic drugs is higher than in general population,the risk factors may include age and long course of disease.
出处 《中国健康心理学杂志》 2012年第6期808-809,共2页 China Journal of Health Psychology
关键词 精神卫生 精神分裂症 非典型抗精神病药 代谢综合征 Mental health; Schizophrenia; Atypical antipsychotic drug; Metabolic syndrome
  • 相关文献

参考文献9

  • 1Newcomer J W. Metabolic considerations in the use of antipsychotic medications : A review of recent evidence[J]. JClin Psychiat, 2007,68 (1):20-27.
  • 2Smith H, Kenney -- Herbert J, Knowles L. Clozapine -- induced dia- betic ketoacidosis[J]. AustNew Zealand J Psychiatry, 1999,33 (1) : 120-122.
  • 3张少平,方芳,陈银娣,汪作为,薛玲妹,罗碧明,肖春兰.非典型抗精神病药相关代谢综合征随访研究[J].精神医学杂志,2009,22(3):182-185. 被引量:5
  • 4李健斋,王抒,曾平.北京市职业人群代谢综合症患病率调查[J].基础医学与临床,2004,24(2):217-221. 被引量:36
  • 5姜素英,章晖,左玉华,刘兰花,原永明,方蓉,蔡伟青,贾伟平,项坤三.上海市曹杨社区20岁以上人群代谢综合征及其相关疾病的流行病学调查[J].上海医学,2003,26(1):3-6. 被引量:49
  • 6De Hert M,van Winkel R,Van Eyck D,et al. Prevalence of diabetes, metabolic syndrome and metabolic abnormalites in schizophrenia over the course of the illness~A cross -- sectional study [J]. Clin Pract Epidemol Ment Health, 2006,2 : 14.
  • 7Lamberti J S,Olson D,Crilly J F,et al. Prevalence of the metabolic syndrome among patients receiving clozapine [J]. Am JPsychiat, 2006,163 (7):1273-1276.
  • 8乔颖,闻晖,陈海莹,项志清,薛振康,宋振华,黄继忠.长期住院治疗的精神分裂症患者代谢综合征风险研究[J].上海精神医学,2008,20(2):65-68. 被引量:21
  • 9Jose Ph P, Me Evoy A, Jonathan M, et al. Prevalence Of themetabolie syndrome in Patients with schizophrenia: Baseline results from the clinical antipsychotic trials of intervention effectiveness (CATIE) Schizophrenia trial and comparison with national estimates from NHANES111 B[J]. SchizoPhrenia Research, 2005,80 : 19- 32.

二级参考文献42

  • 1乔颖,闻晖,陈海莹,项志清,薛振康,宋振华,黄继忠.长期住院治疗的精神分裂症患者代谢综合征风险研究[J].上海精神医学,2008,20(2):65-68. 被引量:21
  • 2Jin H.,Meyer J.M.,Jeste D.V.Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsyehotics:An analysis of 45 published cases[J].Ann Clin Psychiatry,2002,14:59-64
  • 3Koller E.Doraiswamy PM.Cross,JT.risperidone-associated diabetes.Presented at the 85th Annual Meeting of the Endocrine Society[R].Philadelphia,PA,2002:19-22
  • 4Expert Panel on Detection,Evaluation.and Treatment of High Blood Cholesterol in Adults.Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel lid l-J].JAMA,2001,285:2486-2497
  • 5Smith H,Kenney-Herbert J,Knowles L.Clozapine-induced diabetic ketoaeidesis[J].Aust New Zealand J Psychiatry,1999,33(1):120-122
  • 6Saddichha S,Manjunatha N,Ameen S,et al.Metabolic syndrome in first episode schizophrenia-a randomized double-blind controlled,short-term prospective study[J].Schizophr Res,2008,101(1-3):266-272
  • 7De Hert MA.van Winkel R.Van Eyck D.et al.Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsyehotic medication[J].Schizophr Res,2006,83(1):87-93
  • 8De Hert M,Schreurs V,Sweers K,et al.Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia:a retrospective chart review[J].Schizophr Res,2008,101(1-3):295-303
  • 9Henderson DC,Cagliero E,Gray C.et al.Clozpine,diabetes mellitus,weight gain and lipid abnormalities:a fiveyear naturalistic study[J].Am J Psychiatry,2000,157(6):975
  • 10de Leon J,Diaz FJ.Planning for the optimal design of studies to personalize antipsychotic prescriptions in the post-CATIE era:the clinical and pharmacoepidemiological data suggest that pursuing the pharmacogenetics of metabolic syndrome complications (hypertension,diabetes mellitus and hyperlipidemia) may be a reasonable strategy[J].Schizophr Res,2007,96(1-3):185-197

共引文献106

同被引文献158

引证文献15

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部